Good morning.
Futures red but off overnight lows — tech getting hit again after a brutal two-day stretch, but the tape is trying to find a bid. SMH fell another -10% over the last two sessions, worst run since COVID. High-beta momentum names crashed -18%. Memory stocks got obliterated — MU and SNDK down >10%. CoreWeave -14%, Nebius -17%. Meanwhile, software (IGV) held, defense names bottomed, and breadth was actually healthy (11% of SPX hit 52-week highs Thursday). The rotation narrative is real, but so is the leveraged unwind risk — Korean ETF AUM hit $45B (+800% YTD, 2.9% of free float). VXN-VIX spread at 11.1 points (92nd percentile).
No major AH earnings prints, but the memory pricing data dump from overnight is the real signal. UBS lifted 3Q DRAM to +32% QoQ and NAND to +30% QoQ. Bernstein says SK Hynix DRAM gross margins hit 90.9% in Q2. Let that sink in — memory margins are now comparable to Nvidia's. Intel raised Arrow Lake Refresh prices 15% post-launch, first real CPU pricing power in years. TrendForce warns HBM4 contract prices face "a major hike" for 2027.
Asia was a bloodbath — Korea (EWY) led the selloff, SK Hynix down hard despite the blowout margins. The memory rout is indiscriminate, which means opportunity. Demand is not the problem — GPU cloud operators report 100% utilization into a holiday weekend. The concern is supply rotation and position unwinding.
Three themes framing the day:
1. MEMORY MARGIN EXPLOSION IS UNDERAPPRECIATED. The SK Hynix margin number (72% operating margin, basically matches NVDA) is not priced into MU or the Korean names. DRAM contract prices +32% QoQ in Q3. NAND +30%. At these levels, MU's earnings power is materially higher than consensus models reflect. The stock got caught in the neocloud/Meta bare-metal compute panic, but the fundamental tightness in HBM and legacy DRAM is real. We're buyers into weakness.
2. THE ROTATION IS REAL, BUT THE AI CAPEX CYCLE IS NOT BROKEN. Meta selling bare-metal compute spooked the neocloud names (CRWV, NBIS, IREN) — the market read it as capacity oversupply. Counter-argument: if Meta can monetize its DC footprint, that's actually bullish for the ecosystem. The AI ROI debate is getting louder (Bubble Barometer shows ROIC/WACC at 3.05x, still healthy), but the path to $5T total US AI capex by 2030 requires $3-4T annualized revenue. That's a steep bar. Watch VST and CEG — power demand is the bottleneck no one is rotating out of.
3. INTEL HAS A REAL PRODUCT AND REAL PRICING POWER. The Crescent Island GPU (Xe3P, LPDDR5X, air-cooled, H2 2026) is a legitimate data center play. The Arrow Lake price hike is the first evidence of Intel pricing power in years. Samsung is bundling DRAM to win ASIC business (TPU, MTIA, Anthropic talks) — Intel needs to use Micron/USG connections to counter. INTC and MU are linked here — if Intel foundry wins, MU supplies the memory. The US onshoring narrative is underowned.
4. THE DEFENSE / CYBERSECURITY CROSSOVER IS GETTING INTERESTING. Fortinet hardware teardown is getting attention. CRWD is neutral but the sector is rotating into defense names (LMT, RTX, LHX) showing bottoming patterns. If the rotation out of AI semis continues, cybersecurity and defense are natural recipients. FTNT and DDOG are on watch.
We'll hit up MU and SK Hynix first — the memory pricing data is too good to ignore — then get to the semis/defensives rotation play (CRWV, IREN, DDOG).
Verdict: FDS ripping 17% post-print but the tape is still deeply skeptical. AI traction is real – 50% higher ASV growth from AI clients vs. non – but margins remain the wedge issue. Bulls see an inflection; bears see a value trap in a 44%-down stock.
Fiscal Q3 2026 beat on both top and bottom lines: revenue $622.9M vs $617.3M consensus, EPS $4.53 vs $4.45. Organic ASV accelerated for the FIFTH consecutive quarter to +7.1%. That’s the headline. Management guided to the high end of full-year ranges and said Q4 bookings are tracking ahead of a record Q4 last year.
But margin pressure is real. Adjusted operating margins have been sliding for two years. Management blamed timing (higher ASV → higher performance comp) and said the incremental tech investment from the last couple years is now hitting run-rate. Translation: operating leverage should start showing up in FY2027.
Bull case: AI is a multi-year revenue catalyst – ASV from AI clients grew 50% faster than the rest last quarter. Contract durations extended 30%. Management sees this as a large ongoing opportunity given investments in real-time data, managed portfolio services, and private markets. UBS (Buy, PT cut to $340 from $380 on valuation) says near-term trends should drive the stock higher as long-term worries take a backseat.
Bear case: The stock is down 44% for a reason. Revenue growth is still mid-single-digit (+6.6%). Margins are compressing despite the beat. BMO (Market Perform, PT to $275 from $257) called AI "early innings." Wolfe (Underperform, PT to $240) and Wells Fargo (Underweight, PT to $210) are staying negative, arguing the revenue strength won't translate to sustainable earnings power. Jefferies (Hold, PT to $253) modestly raised estimates but isn't buying the inflection story yet.
Consensus is a tug-of-war. UBS lowered its PT but maintained Buy – a signal that the growth trajectory is worth the wait. BMO raised estimates but kept Market Perform. The broadest take: FDS is pricing in a lot of skepticism, but the AI narrative is gaining enough traction to keep the bull camp alive.
“Relative to last quarter, annual subscription value growth from clients using artificial intelligence solutions was 50% higher than for other clients. Trends should remain favorable in the near term, which could drive the stock higher, as long-term worries take a backseat.” – UBS
The bears aren't wrong about the margin picture, but the rate of change on ASV acceleration and AI adoption is the single most important data point right now. If Q4 bookings confirm momentum, the short base (44% down) could squeeze hard. If margins miss again, the $240–250 zone acts as resistance. Keep FDS on the watchlist – the next print could be the tiebreaker.
Stock split is a non-event for the thesis. Barclays cut its PT to $169 (from $675 pre-split) purely to reflect the 4:1 split — multiple unchanged at ~42x FY31 FCF of ~$4.2B. They’re still Overweight. The stock is near its split-adjusted all-time high of $196.50, UP 65% YTD and 70% OVER SIX MONTHS. The split doesn't change the story — it just adds three extra shares to your position.
Meanwhile, the operating narrative keeps improving: earnings beat consensus by 1.7% (a nice reversal from last quarter's miss), and the AI security push continues — expanded Falcon tools on AWS, new agent authorization features, and gateway partnerships with Databricks, Google Cloud, and Azure. Cantor reiterated Overweight at $725 pre-split ($181.25 split-adjusted). The bull case remains intact: platform consolidation, AI tailwinds, and a recovering macro backdrop. The bear case? Valuation is still rich at ~42x FCF, and the July outage scar tissue isn't fully healed for some PMs. But the rate of change is clearly positive.
HSBC goes all-in on the foundry story, doubling its PT to $200 while maintaining Buy. The real move is that they're now including Intel Foundry in their SOTP valuation for the first time — capacity bottlenecks are real, external customers are lining up, and they're penciling in design commitments from 2H26. Numerically, it's a huge delta: HSBC's DC/AI revenue for 2027 sits at $33B, 20% above consensus, driven by a 30% server CPU shipment growth (vs. prior 20%) as 18A ramps.
"We now include Intel Foundry in our sum-of-the-parts valuation after foundry capacity bottlenecks have been widely acknowledged and Intel’s external customer engagement has grown."
The stock is up 481% in the past year — the narrative has fully flipped from "will they survive" to "how much foundry upside is priced in." HSBC is betting there's still room to run, but with the PT at $200 vs. current $123, the implied upside is shrinking. Mizuho at $135 Neutral and Cantor at $150 are more cautious — supply constraints through 2027 and rising memory costs could cap PC demand in 2H26. The bull case here is pure foundry re-rating; the bear case is that server CPU upside is already discounted and the external foundry revenue is still a promise, not a P&L line.
Oppy sticking with Outperform and $84 PT after the ARMS acquisition — they see this as a bridge to a bigger TAM, not just a bolt-on. Stock already up 10% to $44.32 on the news, but still a mile from the target (100%+ upside). ARMS is a coordination software layer that harmonizes people and machines — think of it as Symbotic’s play to serve clients not ready for total lights-out automation. The core thesis: full automation wins long-term, but the transition will be messy and incremental. ARMS lets Symbotic get in the door with those hesitant customers and migrate them over time.
“The acquisition expands Symbotic’s technology portfolio and is a potential precursor to expanding its offerings to include applications with increased levels of human and robot interaction.”
Context check: Q2 FY2026 was a mixed bag — revenue beat ($676M vs $662M est.) but EPS horrid ($0.01 vs $0.12 consensus). Insider Director Krasnow sold 26k shares after a redemption event — noise but worth flagging if PMs are positioning for a catalyst-driven re-rate. Next catalyst: Q2 earnings call (presumably soon) where management should drop more color on ARMS integration and customer pipeline.
Verdict: The photomask play is cheap for a reason, but the capacity cycle narrative is real. Freedom Broker initiates Buy with $41 PT, citing the $330M capex cycle (largest ever) and expansion into US/Korea for sub-28nm and AMOLED. Stock at $30.12 — down 7.7% in a week, P/E 11.22, PEG 0.28. That is not expensive for a semi equipment supplier with structural demand tailwinds.
But the near-term numbers are horrid. Q2 missed: EPS $0.42 vs $0.53 est, revs $209.9M vs $216.7M. Q3 guide midpoint $211M vs $218.5M consensus and EPS $0.39-0.45. Craig-Hallum cut PT to $42 (from $48) but kept Buy, pointing to IC softness, memory supply constraints, and geopolitical delays. Management says tape-outs started recovering in May — the rate of change there is everything.
"The stock has experienced recent pressure, creating what the firm views as an attractive entry point at current valuation levels."
That is the bull case in one line — you're paying for a cyclical trough in a structural growth story. The bear case: this could get worse before it gets better if the "initial signs of recovery" don't compound. Q3 guidance implies no sequential improvement. We need to see the May tape-out uptick translate into Q4 revenue before we get aggressive.
The PEG of 0.28 gets our attention, but PMs should wait for confirmation that the demand recovery isn't another false start. This is a r/r trade — not a conviction long yet.
BUYING OPPORTUNITY — ROSENBLATT HOLDS $250 PT. CRWV at $85.69, down 13% in the last week. The street's knee-jerk was to sell on Meta’s cloud ambitions. But Rosenblatt’s McPeake says not so fast — Meta cannot resell any capacity leased from CoreWeave through 2032. Their checks show GPU shortages are the norm, hyperscale procurement posture unchanged. This is noise, not signal.
“The firm also said it does not believe Meta has the right to resell any capacity it has leased from CoreWeave through 2032 to third parties.”
Rosenblatt reiterates Buy, $250 PT. The risk? Meta does overbuild and eventually competes — but that’s a 2028+ story, not today’s. For PMs: the rate of change on GPU supply remains tight, and CRWV’s existing contracts are locked. Weakness is a gift if you have the stomach for AI infra vol.
Canaccord initiates with a Buy and $22 PT (~70% upside) — but this is a call on optionality, not earnings power. The thesis is built on INFQ’s dual model: they sell quantum sensing products (atomic clocks, RF receivers, inertial nav) today to defense/aero customers, while developing neutral-atom quantum computing for tomorrow. Canaccord sees a path to revenue scaling before quantum compute becomes a commercial reality. The stock trades at $12.93, market cap ~$2.8B, on $33.6M LTM revenue (31% gross margin). Cash position is $569M with zero debt — enough runway for years.
“Infleqtion’s dual model anchors our Buy.”
The bull case rests on near-term hardware sales funding long-term compute R&D, plus a $100M CHIPS LOI. Q1 revenue grew 14% YoY to $9.5M. But operating losses are still $33.6M/quarter (mostly SBC and public company costs). Profitability isn’t on the 2026 horizon — even the initiating analyst doesn’t call for it. This is a high-conviction narrative stock for PMs who can stomach negative GAAP earnings for years.
The bear case writes itself: $2.8B market cap on <$35M revenue is rich for a hardware company. Quantum compute is pre-revenue for everyone. Defense contracts can be lumpy. The $100M LOI with CHIPS is non-binding and milestone-dependent. And INFQ is a SPAC orphan — the go-public transaction overhang and SBC dilution are real. Not sure we can read much into a single initiation at this stage, but the dual-revenue thesis is cleaner than most pure-play quantum names. Keep on the watchlist; don't size up until you see consistent beat-and-raise.
Verdict: Deeply mispriced AI-enabled data network. Stifel reiterates Buy and $9 PT (stock at $5.38 — ~40% discount to consensus $8.50). Thesis: the market is blind to Clarivate’s competitive moat, network effects, and AI tailwinds. Valuations are absurd — PEG of 0.27. The firm thinks the CEO should just take it private because the numbers work and the business doesn’t need a turnaround.
“The market lacks appreciation of Clarivate’s competitive moat, network effect, and artificial intelligence tailwind given the current low valuation.”
Stifel sees a multi-year hold: wait for AI disruption dust to settle, then exit via IPO, sponsor sale, or strategic. That’s a patient alpha play for PMs who can stomach the waiting — but the r/r here is asymmetric if the moat thesis holds.
Verdict: Bullish signals stacking up. D.A. Davidson reiterates Buy after the stock rips 12.9% in a week to $612.91. The thesis is clean: AI driving ad volume and pricing, revenue acceleration of 26% LTM, gross margins at 82%. The capex overhang is the only real caveat — but if Meta slows spend and starts monetizing, that’s alpha.
“If Meta slows down capex and starts monetizing it, there could be upside to revenue and cash flow.” — D.A. Davidson
The broker consolidation is telling: Wells Fargo PT $767, BofA $835, Mizuho $835. That’s a cluster of $767-835 vs. current $612. The common thread? AI monetization and the Neocloud pivot. Citizens called out the Compute business as industry-disruptive. META’s building a cloud biz that’s already rattling Korean memory suppliers — worth watching for both revenue optionality and capex trajectory.
Bottom line: the narrative is shifting from “capex horror story” to “platform build → monetization flywheel.” Rate of change is positive. Positioning is still light relative to the Megacap 6 peers. If Q2 print (revenue est $60.7B, +28%) confirms, this thing grinds toward $700+ before year-end.
Truist sees 28% upside post-Ruckus close. Raised PT to $155 from $150 (15.5x CY27 EPS), maintaining Buy. The acquisition closed July 1 — now they’ve got a combined model. Expectation is more solution selling drives faster top-line and fatter margins.
“The combined company should generate more revenue from solution selling, resulting in faster total sales growth and higher profitability.”
EPS ESTIMATE JUMPED TO $9.95 FROM $9.20 for CY27. That 15.5x multiple still sits at a 5.5x discount to the S&P 500 — cheap for a networking play with Ruckus’s enterprise and carrier exposure layered on. Vistance pocketed ~$1.75B net from the sale, so BDC paid up, but Truist thinks the r/r works.
BDC also quietly launched four new OT network products (distributed I/O, wireless, switching, cybersecurity) and a new fiber drop cable. Not the headline grabber, but helps the narrative of a broader industrial networking platform.
One analyst, one model, one take: post-deal accretion, margin expansion, discount to market. Light coverage, clean signal.
Verdict: Execution is the story here. Compass Point kept Buy / $70 after APLD hit Ready for Service on Phase 1 of Building 2 at Polaris Forge 1 – 75 MW delivered on time, bringing total live campus capacity to 175 MW from 100 MW. That’s a tangible derisking of the CoreWeave ramp. Stock is down 13% in the last week to ~$35.50, despite a 236% one-year return. The gap between closing prices post each lease announcement (April/May/June) and the current tape suggests the market is asking “what’s next?” more than it’s doubting delivery.
"The on-time delivery reduces risk around the CoreWeave ramp and reinforces Applied Digital’s execution capabilities across future AI factory campuses."
Total contracted base-term revenue is now ~$36B (from ~$16B after three leases). Phase 2 of Building 2 (final 150 MW of the 400 MW campus) expected mid-calendar 2027. Six data halls energizing across July-September – that’s revenue ramp visible in the August and November quarters. Northland’s Mike Grondahl also raised PT to $82 (from $56) after APLD leased 810 MW to a new hyperscaler. Separate from this, APLD subsidiary priced $1.59B of 7% senior secured notes due 2031 – costly capital, but the financing stays ahead of the build.
Bull case: Execution cadence is real. On-time delivery + fully leased campus + hyperscaler expansion = compounding narrative. $70 PT from Compass Point may look conservative if the 400 MW CoreWeave block hits full run-rate next year.
Bear case: 7% debt is expensive. Stock has already priced a lot of the lease wins. Next catalyst? Need to see the revenue flow through P&L to justify the $36B contract backlog vs. current market cap.
Benchmark goes Street high with a $330 target (from $260), joining a parade of 38 analyst estimate revisions higher. DDOG’s DASH conference momentum + 2 largest AI lab wins in Q1 are driving the narrative: this is the control plane for AI-driven observability, not just a monitoring tool. Stock is up 98% in six months, now at $264 – a $94B market cap – so this re-rating is happening in real time.
The bullish case rests on product-led growth + 80% gross margins funding a $1B+ R&D budget. Benchmark’s analyst specifically called out Bits AI Agents as the center of the transformation – think of it as a command layer for autonomous IT ops. That’s the bull case.
"Datadog’s long-term strategy is to evolve its cloud observability platform into a command control plane for AI-driven systems and autonomous IT operations, with Bits AI Agents positioned at the center of the transformation."
BMO also raised to $260 (from wherever) and Bernstein kept Outperform at $180 – so the Street is converging higher, but Benchmark is the outlier at $330. Not sure we can read too much into a single Street high until others follow, but the rate of change is clearly positive. Risks: stock is 22x next 12 months sales (rough math) and valuation is no longer the friend. But in a momentum market, narratives matter – and DDOG has one of the cleanest AI tailwinds in cloud infrastructure.
NEEDHAM UPGRADED SILICOM TO BUY FROM HOLD with a $60 PT (3.2x EV/sales on 2027E) after the company passed qualification with a new AI inference customer and received initial production orders. The stock is already up 201% YTD to $44.18 — trading near the 52-week high of $52.95 — so the upgrade is more about acceleration of the timeline than a new discovery.
“Inference revenues to total multi-million dollars in 2026 and could reach tens of millions of dollars in 2027.”
That’s the key rate-of-change signal. Needham sees Tier 1 design wins across inference, cybersecurity, and Post-Quantum Cryptography adding upside to estimates and accelerating the return to breakeven. The $3M annual deal with a European encryption firm and the white-label switch win with a global cybersecurity player back up the narrative — this isn’t just an inference story. You’re paying for a multi-year inflection in a ~$400M market cap name that still isn’t profitable this year. High risk/reward, but the narrative trajectory is clear.
JPMorgan sees more room to run. PT to EUR190 from EUR170 (still Overweight), rolling forward to December 2027 vs June 2027. The call is all about fiber pricing upside flowing through Digital Solutions estimates — 2026/27 adj. EBITDA raised 3% and 5% respectively. JPM now models EUR2,890M for 2026, which sits below the EUR2,950M low end of Prysmian’s 2028 medium-term guidance but above the EUR2,625-2,755M near-term range. That gap tells you the trajectory they’re baking in.
Q2 preview: 6.7% organic growth, EUR713M adj. EBITDA (vs EUR605M last year). JPM notes this growth rate SIGNIFICANTLY ABOVE cable peers NKT and Nexans. The PEG ratio of 0.34 is the headline valuation argument — cheap for the growth rate.
“JPMorgan noted this growth rate is significantly above cable peers NKT and Nexans.”
Next catalyst: Q2 results July 30, and more importantly — formal framework agreements with U.S. hyperscalers + capacity expansion updates. That’s the narrative accelerant this stock needs to hold the recent 132% return. Fiber pricing is the near-term driver, hyperscaler capex is the multi-year compounder.
Bottom line: JPM is leaning into the Digital Solutions re-rate. If Prysmian delivers the Q2 beat and closes those hyperscaler deals, the EUR190 target starts looking conservative.
UBS bumps PT to $110 from $92, maintains Buy. Stock at $91.58 — up 119% in the last year, now 1% off the 52-week high. The call is about demand momentum, not valuation.
The firm did ~15 industry checks before upgrading in March. Those checks are paying off: solid demand backdrop, multiple AI tailwinds, and "few signs of competitive pressure." UBS sees 26% and 25% revenue growth in FY26/27. They acknowledge the 48x CY27 FCF multiple is elevated and positioning incremental risk, but they expect the narrative to keep improving.
The broader pack agrees — Cantor at $80, Benchmark and TD Cowen both at $100. All citing AI-driven software development and JFrog’s artifact-centric platform positioning. Consensus rating is 1.32 (Strong Buy cluster).
"The setup for the stock remains attractive despite its recent run." — UBS analyst Radi Sultan
Bears worry about the multiple and AI token optimization risk. (UBS notes the impact is still an open question.) But right now the rate of change in cloud growth and the lack of competitive pressure are the dominant vectors. This is a narrative-driven name at a rich price — PMs need to decide if the 50% cloud growth can sustain.
MU — DRAM pricing acceleration is the real story: UBS sees Q3 +32% QoQ, Q4 +18% QoQ. 16 LTAs with binding volume and price floors convert MU from cyclical commodity to quasi-contract manufacturer. Memory spend hitting 30-40% of hyperscaler capex by YE26 is a structural repricing catalyst the market hasn’t fully discounted. The Burry short is noise against this fundamental force – he’s betting on a mean-reversion that won’t happen until capacity catches up, years away.
NVDA — Memory content in NVDA systems reaching 30-40% of hyperscaler capex shifts the debate from GPU-only to total system cost. Revenue-sharing agreements with AI cloud partners (Firmus, 360 MW with $25-30B offtake) transform from one-time chip sales to recurring revenue. The bear case centers on custom silicon erosion at the inference edge, but the Blackwell ecosystem (CUDA, Tensor Cores) remains a durable moat. Near-term friction from weekly server rack price swings is operational, not structural.
TSM — 18 fabs underway globally, capex guiding to $78B next year, gross margins expected at 67.3% by 2028 – this is not a company seeing demand slowdown. Samsung’s bundling of memory+foundry for Google TPU and Meta MTIA design wins is a competitive threat on leading-edge nodes. SPHBM4 standard could weaken TSMC’s CoWoS monopoly, but CoPoS packaging (mass production H1 2029) is their answer. The risk that massive capacity additions eventually create oversupply is real but years away.
AMD — Pivoting from HBM to LPDDR5X for new Versal Premium Gen 2 is a clever cost-saving and supply diversification play, signaling a focus on inference over training. Custom silicon for hyperscalers (80%+ margins) vs. renting compute (~40%) shows a strategic advantage. Yet training share remains ~10% vs. NVDA’s ~80%. Whale accumulation of AMD calls on the dip suggests institutional conviction that it’s a cheaper AI infrastructure proxy, but it still lags in the high-value training segment.
COHR — Prepaid AXT $22.3M for 6-inch InP wafers and received a $50M CHIPS Act award – that locks in critical substrate supply for optical transceivers at a time InP prices are up 250%. The NVDA partnership is the demand anchor, but Coherent is bottlenecked, even buying EML lasers from Lumentum. Doubling internal InP capacity by end of CY2026 and again by CY2027 signals multi-year visibility. The moat is vertical integration; the risk is technology obsolescence if microLEDs or CPO displace pluggables.
LITE — Completely sold out for the next 2 years, likely into 2029 – even buying CW lasers from competitors. That gives maximum pricing power and revenue visibility. Coherent buying EML lasers from Lumentum confirms a technology edge in high-end optical components. The key execution risk is scaling precision manufacturing without yield degradation; if yields slip, the sellout position becomes a liability. The stock’s recent -18% drawdown is sentiment-driven, not fundamental.
AKAM — The $1.8B cloud service deal with Anthropic is transformative – it repositions Akamai from legacy CDN to edge AI compute provider for low-latency inference. This validates the thesis that traditional CDN networks can be AI distribution assets. The contract size ($1.8B vs. ~$4B revenue) could accelerate growth from mid-single to double digits. The question is whether this is a one-off or the first of many – if Akamai can capture a niche avoiding hyperscaler lock-in, the multiple expansion could be significant.
GPN — Travel accounts for 5% of revenue, with Middle East exposure creating a 60-90 bps headwind to growth. That’s modest but adds pressure to a company already facing slower growth. The stock is likely to underperform if regional disruptions persist; in a low-growth payments environment, even small headwinds can trigger earnings misses. This is a tactical negative, not a structural breakdown.
FTNT — A detailed third-party teardown and performance review of the FG-60F surfaced, independently validating hardware competitiveness. This is a positive signal for enterprise confidence in the mid-market security appliance segment. With PANW, CRWD, and S all vying for the same customer base, any third-party validation can accelerate share gains. The key is whether the teardown highlights any vulnerabilities competitors can exploit.
SSNLF — Samsung targeting Q3 DRAM ASP increases up to 20% QoQ, following prior quarters of 50-60% sequential gains. LPDDR has ‘severe bottlenecks’ with >20% increases – the memory upcycle is broadening beyond HBM to commodity DRAM. Samsung is leveraging its memory supply to win foundry/logic design wins (Google TPU, Meta MTIA, early Anthropic ASIC talks). The bundling strategy is a powerful weapon against TSMC and Intel Foundry, but risks diverting resources from pure memory leadership. KOSPI volatility from leveraged ETF unwinding (8% crash then 8.8% surge) is a market structure risk, not fundamental.
SKHKF — SK Hynix DRAM contract prices rose >80% QoQ, gross margins hit 92.7%, operating margin ~72% matching Nvidia. Q1 2026 profit ($26.15B) exceeded total 2023 revenue. Holds ~60% share of HBM as Nvidia’s primary supplier, with HBM4 set to bring substantial price hikes per TrendForce. The Nasdaq listing next week will increase US accessibility and potentially reduce the Korean leverage overhang. LTAs with Nvidia have no price caps, giving full pricing flexibility – a key advantage over Micron’s floor/ceiling structure. The risk is Samsung catching up on HBM4 and Nvidia dual-sourcing.
KIOXF — Sampling 10th-gen 332-layer 3D NAND to AI data centers, with 59% more capacity than 8th-gen – a strategic pivot from smartphone to AI SSDs. The stock reversed double-digit losses and rose 8.9% on the announcement. Kioxia holds only ~10% of data-center NAND market vs. Samsung’s 40%, but chips are touted as superior in data processing speed. NAND pricing is also rising (Q3 +10-15% QoQ), and the pivot to data centers should capture more of the upcycle. Shares up >680% YTD but volatile – sustainability concerns linger.
SNDK — In a bear market, down 26% from June all-time high, but NAND pricing is still rising (Q3 +10-15% QoQ). The drop is sentiment and forced selling, not fundamentals. SanDisk is now standalone after splitting from WD, with brand strength in retail/consumer SSDs. But it’s a minor player in AI data center SSDs – the long-term growth story depends on that mix shift. The 26% drawdown may be overdone relative to the NAND pricing outlook.
AXT — Signed a 3-year, $22.3M supply agreement with Coherent for 6-inch InP wafers – validation as one of only two global InP substrate suppliers (with Sumitomo, controlling ~80% combined). InP prices surged 250% to ~$5,000, partly due to China export restrictions. The geopolitical angle is the key swing factor: US permits are still pending, creating binary outcomes. AXT’s pricing power is immense, but regulatory uncertainty caps upside.
TSLA — Robotaxi service went live in Miami; first production Cybercab engineering tests began in Austin. Q2 deliveries were a record 480,126 vehicles – but margin recovery is slow amid price cuts. FSD-compatible fleet crossing 10M vehicles is a massive data advantage, but competition from Waymo and Chinese players intensifies. Cathie Wood bought 96,935 shares – institutional conviction in the robotaxi thesis. The fatal Semi accident raises safety scrutiny.
PLTR — Some US government customers switched from proprietary AI models to Nvidia’s open-source Nemotron models, per CEO Karp – a direct threat to Palantir’s closed-source offerings. Karp’s public criticism of token-based pricing suggests pressure from open-source alternatives. The ‘applied AI layer’ thesis argues embeddedness in government workflows is a sustainable moat, but if open-source models can be fine-tuned easily, that moat shrinks. Defense stocks bottoming may renew interest in defense tech, but the switch to open-source is a negative for Palantir’s legacy business.
IREN — Co-CEO compensation grants totaling ~$706.5M (5.45% of market cap) with no performance conditions triggered a 10.4% stock decline – egregious governance that sets a sector precedent. The pivot from bitcoin mining to AI cloud services is now tainted by agency risk. Institutional investors will avoid the name, raising cost of capital for its AI pivot. Peer comps like Hut 8, Cipher, TeraWulf have performance-conditioned compensation – IREN is an outlier.
NBIS — Dropped 17% on the Meta compute news, similar to CoreWeave, but Meta is a contracted customer, not a competitor. Nebius’s European full-stack offering with data sovereignty tailwinds differentiates it from US-based neoclouds. The selloff may be an overreaction, but the sentiment shift is powerful. If the overreaction persists, it could create a buying opportunity for those who believe European AI regulation favors Nebius.
ORCL — Fell for 9 consecutive days, losing 24%, its longest losing streak since Dec 2021. The selloff is part of the broader tech rotation, but ORCL is a proxy for enterprise AI adoption. Competing with hyperscalers for AI workloads; the multi-cloud strategy has some traction, but the market is losing patience. The CDS blowout (2-month wides) suggests credit stress – a warning sign. The debate is whether ORCL’s AI revenue is material enough to reverse sentiment.
CEG — Power grid (PJM) hit record demand; data centers driving 63% of capacity price increases. Community pushback blocking $130B in data center projects creates a bottleneck that benefits existing generators like CEG. Natural gas generation ramped 40% over 11 days, highlighting the need for new baseload. CEG’s nuclear fleet is always-on, carbon-free, highly valued by hyperscalers for ESG targets. The scarcity premium is expanding, but if regulatory responses accelerate permitting, the premium could fade.
VST — Similar to CEG, benefits from the same power demand spike. PJM capacity prices are spiking; VST’s gas and nuclear assets are in high demand. The key difference is higher reliance on natural gas, exposing it to fuel price volatility. VST competes with CEG for hyperscaler PPAs but is more a play on spot power pricing than long-term contracted revenue. The stock is part of the rotation from semis to utilities.
MCHP — Announced price adjustments effective Aug 14, 2026, due to rising costs – a sign of cost inflation but also pricing power. Microchip is a microcontroller and analog player, less directly exposed to AI but benefiting from general industrial and automotive demand. The price increase could support margins if volumes hold. Not an AI direct play, but a beneficiary of the broader semiconductor upcycle.
UMC — TSMC’s capacity discipline is creating overflow business for specialty foundries like UMC. As customers seek alternative capacity, UMC could see higher utilization and pricing on mature nodes. The key is whether it can capture high-margin specialty chips (RF, power management) to boost margins. A tactical play on capacity spillover without paying TSMC’s premium.
GFS — Another beneficiary of TSMC capacity spillover, with strengths in RF, analog, and power ICs for 5G, automotive, IoT. US-based fabs and CHIPS Act support give it a valuation premium over Asian foundries. The onshoring push and export controls are unique tailwinds. The rotation into GFS reflects a bet on non-AI semiconductor demand, but the quality of the business and regulatory support make it a more durable play than UMC.
LRCX — Semicap equipment names sustain memory capex; UBS forecasts DRAM undersupply until at least 2028. Lam’s order backlog is driven by long-term capacity planning, not spot pricing. Memory makers are spending heavily – SK Hynix alone on pace for >$100B profit funds aggressive capex. The recent memory stock selloff should not affect Lam’s revenue trajectory; equipment orders will remain elevated for years.
AMAT — Leveraged to both memory and logic capex. TSMC’s $78B capex next year is a strong signal for wafer fab equipment. Exposure to China memory (CXMT) is a manageable headwind from export controls. The overall semi equipment TAM is expanding, and AMAT’s diversified portfolio captures a broad share. The recent drawdown is an opportunity to buy at a discount.